thalidomide has been researched along with Pemphigus in 9 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
Pemphigus: Group of chronic blistering diseases characterized histologically by ACANTHOLYSIS and blister formation within the EPIDERMIS.
Excerpt | Relevance | Reference |
---|---|---|
"Thalidomide (Tha) can be used as a selective treatment for mild pemphigus vulgaris (PV)." | 8.31 | Thalidomide Alleviates Apoptosis, Oxidative Damage and Inflammation Induced by Pemphigus Vulgaris IgG in HaCat Cells and Neonatal Mice Through MyD88. ( Chen, J; Chen, M; Li, X; Lu, Z; Luan, C; Zhao, R, 2023) |
"To determine whether apremilast, an inhibitor of the PDE4 normally used in psoriasis, may be of benefit in the blistering skin disorder pemphigus." | 7.96 | Case Report: Apremilast for Therapy-Resistant Pemphigus Vulgaris. ( Ghoreschi, K; Holstein, J; Meier, K; Solimani, F; Waschke, J, 2020) |
"Pemphigus vegetans is a rare variant of pemphigus vulgaris." | 5.62 | Post-cesarean section pemphigus vegetans in a young woman treated with methylprednisolone and thalidomide. ( Jiang, L; Li, W; Qiu, X; Yuan, P, 2021) |
"Thalidomide is a medication with strong anti-inflammatory, immunomodulatory, antiangiogenic, and sedative properties." | 5.56 | Thalidomide as a potential adjuvant treatment for paraneoplastic pemphigus: A single-center experience. ( Pan, M; Wang, J; Zhang, Y, 2020) |
"Thalidomide (Tha) can be used as a selective treatment for mild pemphigus vulgaris (PV)." | 4.31 | Thalidomide Alleviates Apoptosis, Oxidative Damage and Inflammation Induced by Pemphigus Vulgaris IgG in HaCat Cells and Neonatal Mice Through MyD88. ( Chen, J; Chen, M; Li, X; Lu, Z; Luan, C; Zhao, R, 2023) |
"To determine whether apremilast, an inhibitor of the PDE4 normally used in psoriasis, may be of benefit in the blistering skin disorder pemphigus." | 3.96 | Case Report: Apremilast for Therapy-Resistant Pemphigus Vulgaris. ( Ghoreschi, K; Holstein, J; Meier, K; Solimani, F; Waschke, J, 2020) |
"Pemphigus vegetans is a rare variant of pemphigus vulgaris." | 1.62 | Post-cesarean section pemphigus vegetans in a young woman treated with methylprednisolone and thalidomide. ( Jiang, L; Li, W; Qiu, X; Yuan, P, 2021) |
"Thalidomide is a medication with strong anti-inflammatory, immunomodulatory, antiangiogenic, and sedative properties." | 1.56 | Thalidomide as a potential adjuvant treatment for paraneoplastic pemphigus: A single-center experience. ( Pan, M; Wang, J; Zhang, Y, 2020) |
"Castleman disease is a rare lymphoproliferative disorder." | 1.35 | Successful immunomodulatory therapy in castleman disease with paraneoplastic pemphigus vulgaris. ( Gonda, A; Illes, A; Miltenyi, Z; Remenyik, E; Tar, I; Toth, J, 2009) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (11.11) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (22.22) | 29.6817 |
2010's | 2 (22.22) | 24.3611 |
2020's | 4 (44.44) | 2.80 |
Authors | Studies |
---|---|
Luan, C | 1 |
Lu, Z | 1 |
Chen, J | 1 |
Chen, M | 1 |
Zhao, R | 1 |
Li, X | 1 |
Wang, J | 1 |
Zhang, Y | 1 |
Pan, M | 1 |
Meier, K | 1 |
Holstein, J | 1 |
Solimani, F | 1 |
Waschke, J | 1 |
Ghoreschi, K | 1 |
Qiu, X | 1 |
Yuan, P | 1 |
Li, W | 1 |
Jiang, L | 1 |
Miltenyi, Z | 1 |
Toth, J | 1 |
Gonda, A | 1 |
Tar, I | 1 |
Remenyik, E | 1 |
Illes, A | 1 |
Szturz, P | 1 |
Adam, Z | 1 |
Klincová, M | 1 |
Feit, J | 1 |
Krejčí, M | 1 |
Pour, L | 1 |
Zahradová, L | 1 |
Vašků, V | 1 |
Hájek, R | 1 |
Mayer, J | 1 |
Lee, FC | 1 |
Cunha, PR | 1 |
de Oliveira, JR | 1 |
Salles, MJ | 1 |
Jamora, J | 1 |
Bystryn, JC | 1 |
Schnitzler, L | 1 |
9 other studies available for thalidomide and Pemphigus
Article | Year |
---|---|
Thalidomide Alleviates Apoptosis, Oxidative Damage and Inflammation Induced by Pemphigus Vulgaris IgG in HaCat Cells and Neonatal Mice Through MyD88.
Topics: Acantholysis; Animals; Animals, Newborn; Apoptosis; bcl-2-Associated X Protein; Caspase 3; HaCaT Cel | 2023 |
Thalidomide as a potential adjuvant treatment for paraneoplastic pemphigus: A single-center experience.
Topics: Humans; Neoplasm Recurrence, Local; Paraneoplastic Syndromes; Pemphigus; Prednisone; Thalidomide | 2020 |
Case Report: Apremilast for Therapy-Resistant Pemphigus Vulgaris.
Topics: Drug Resistance; Female; Humans; Middle Aged; Pemphigus; Phosphodiesterase 4 Inhibitors; Thalidomide | 2020 |
Post-cesarean section pemphigus vegetans in a young woman treated with methylprednisolone and thalidomide.
Topics: Autoimmune Diseases; Cesarean Section; Female; Humans; Methylprednisolone; Pemphigus; Pregnancy; Tha | 2021 |
Successful immunomodulatory therapy in castleman disease with paraneoplastic pemphigus vulgaris.
Topics: Adrenal Cortex Hormones; Castleman Disease; Cyclosporine; Female; Humans; Immunomodulation; Immunosu | 2009 |
Multiple myeloma associated IgA pemphigus: treatment with bortezomib- and lenalidomide-based regimen.
Topics: Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Female; Humans; Immunoglo | 2011 |
Longterm clinical remission of oral and cutaneous pemphigus with thalidomide.
Topics: Female; Humans; Immunosuppressive Agents; Lip Diseases; Middle Aged; Mouth Diseases; Pemphigus; Thal | 2011 |
Pemphigus vulgaris with involvement of the cervix treated using thalidomide therapy.
Topics: Azathioprine; Diagnosis, Differential; Drug Administration Schedule; Drug Therapy, Combination; Fema | 2004 |
[Beneficial effect of thalidomide in a case of Hailey-Hailey pemphigus. 1 years' trial].
Topics: Aged; Female; Humans; Pemphigus; Thalidomide; Time Factors | 1984 |